Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 432

Similar articles for PubMed (Select 15564948)

1.

Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia.

Gottrup H, Juhl G, Kristensen AD, Lai R, Chizh BA, Brown J, Bach FW, Jensen TS.

Anesthesiology. 2004 Dec;101(6):1400-8.

PMID:
15564948
2.

Gabapentin suppresses cutaneous hyperalgesia following heat-capsaicin sensitization.

Dirks J, Petersen KL, Rowbotham MC, Dahl JB.

Anesthesiology. 2002 Jul;97(1):102-7.

PMID:
12131110
3.

Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans.

Iannetti GD, Zambreanu L, Wise RG, Buchanan TJ, Huggins JP, Smart TS, Vennart W, Tracey I.

Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18195-200. Epub 2005 Dec 5.

4.

Effect of chronic oral gabapentin on capsaicin-induced pain and hyperalgesia: a double-blind, placebo-controlled, crossover study.

Wallace MS, Schulteis G.

Clin J Pain. 2008 Jul-Aug;24(6):544-9. doi: 10.1097/AJP.0b013e3181673b93.

PMID:
18574364
5.
6.
7.
8.

AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans.

Sang CN, Hostetter MP, Gracely RH, Chappell AS, Schoepp DD, Lee G, Whitcup S, Caruso R, Max MB.

Anesthesiology. 1998 Nov;89(5):1060-7.

PMID:
9821993
9.
10.

Topically administered ketamine reduces capsaicin-evoked mechanical hyperalgesia.

Pöyhiä R, Vainio A.

Clin J Pain. 2006 Jan;22(1):32-6.

PMID:
16340591
11.

Effect of morphine and pregabalin compared with diphenhydramine hydrochloride and placebo on hyperalgesia and allodynia induced by intradermal capsaicin in healthy male subjects.

Wang H, Bolognese J, Calder N, Baxendale J, Kehler A, Cummings C, Connell J, Herman G.

J Pain. 2008 Dec;9(12):1088-95. doi: 10.1016/j.jpain.2008.05.013.

PMID:
19038771
12.

Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers.

Chizh BA, Göhring M, Tröster A, Quartey GK, Schmelz M, Koppert W.

Br J Anaesth. 2007 Feb;98(2):246-54.

14.

Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia.

Klein T, Magerl W, Hanschmann A, Althaus M, Treede RD.

Eur J Pain. 2008 Jan;12(1):17-29. Epub 2007 Apr 20.

PMID:
17449306
15.

Adding gabapentin to a multimodal regimen does not reduce acute pain, opioid consumption or chronic pain after total hip arthroplasty.

Clarke H, Pereira S, Kennedy D, Andrion J, Mitsakakis N, Gollish J, Katz J, Kay J.

Acta Anaesthesiol Scand. 2009 Sep;53(8):1073-83. doi: 10.1111/j.1399-6576.2009.02039.x. Epub 2009 Jun 30.

PMID:
19572933
16.

Antinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic pain.

Chen SR, Samoriski G, Pan HL.

Neuropharmacology. 2009 Aug;57(2):121-6. doi: 10.1016/j.neuropharm.2009.04.010. Epub 2009 May 5.

17.

Morphine, gabapentin, or their combination for neuropathic pain.

Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL.

N Engl J Med. 2005 Mar 31;352(13):1324-34.

18.
19.

Intradermal glutamate and capsaicin injections: intra- and interindividual variability of provoked hyperalgesia and allodynia.

Nilsson M, Lassen D, Andresen T, Nielsen AK, Arendt-Nielsen L, Drewes AM.

Clin Exp Pharmacol Physiol. 2014 Jun;41(6):423-9. doi: 10.1111/1440-1681.12229.

PMID:
24684312
20.

Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379].

van de Vusse AC, Stomp-van den Berg SG, Kessels AH, Weber WE.

BMC Neurol. 2004 Sep 29;4:13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk